Galantamine reduces caregiver time spent providing assistance to individuals with mild-to-moderate Alzheimer's disease.

被引：0

作者：

Kaufer, DI

Sadik, K

机构：

[1] Univ Pittsburgh, Pittsburgh, PA USA

[2] Janssen Pharmaceutica Prod LP, Titusville, NJ USA

来源：

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2002年 / 10卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：84 / 85

页数：2

共 50 条

[1] Galantamine reduces time spent by caregivers in providing assistance for patients with Alzheimer's disease.
Kaufer, DI
Sadik, K
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S25 - S25
[2] Galantamine reduces behavioral and psychological disturbances and behavior-related caregiver in mild-to-moderate Alzheimer's disease
Monsch, AU
Krebs-Roubicek, E
Braendle, D
Hock, C
[J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 349 - 349
[3] Galantamine has a broad spectrum of efficacy in mild-to-moderate Alzheimer's disease.
Mintzer, JE
Kershaw, P
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S23 - S23
[4] Galantamine reduces behavioral and psychotic disturbances and behavior-related caregiver burden in mild-to-moderate Alzheimer's disease
Monsch, A
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S368 - S369
[5] Galantamine reduces behavioral and psychotic disturbances and behavior-related caregiver burden in mild-to-moderate Alzheimer's disease
Monsch, AU
Krebs-Roubicek, E
Braendle, D
Hock, C
[J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S120 - S120
[6] Galantamine-ER for the treatment of mild-to-moderate Alzheimer's disease
Seltzer, Ben
[J]. CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 1 - 6
[7] Gastrointestinal tolerability of once-daily galantamine in subjects with mild-to-moderate Alzheimer's disease
Dunbar, F
Zhu, Y
Brashear, R
[J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 312 - 312
[8] Safety and effectiveness of galantamine for mild to moderate Alzheimer's disease
Alvarez, F. J.
Blesa, R.
Ezpeleta, D.
Romo, I.
Garcia-Ribas, G.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 73 - 73
[9] Economic impact of galantamine in mild to moderate Alzheimer's disease
Caro, J
Migliaccio-Walle, K
Ishak, KJ
Getsios, D
O'Brien, JA
Papadopoulos, G
[J]. ANNALS OF NEUROLOGY, 2001, 50 (03) : S79 - S79
[10] Memantine in the treatment of mild-to-moderate Alzheimer's disease
Cosman, Kelly M.
Boyle, Llsa L.
Porsteinsson, Anton P.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (02) : 203 - 214

← 1 2 3 4 5 →